Logo image of BTAI

BIOXCEL THERAPEUTICS INC (BTAI) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:BTAI - US09075P2048 - Common Stock

1.71 USD
-0.02 (-1.16%)
Last: 12/24/2025, 3:12:51 PM
1.7091 USD
0 (-0.05%)
After Hours: 12/24/2025, 3:12:51 PM
Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to BTAI. The Buy consensus is the weighted average rating of the current analysts ratings.

BTAI was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about BTAI.
In the previous month the buy percentage consensus was at a similar level.
BTAI was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
BTAI Historical Analyst RatingsBTAI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -91 -83 -75 -67 -59 -51 -43 -35 -27 -19 -11 -3 5 10 15
BTAI Current Analyst RatingBTAI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-09-15 HC Wainwright & Co. Reiterate Buy -> Buy
2025-09-12 Mizuho Maintains Neutral -> Neutral
2025-08-28 HC Wainwright & Co. Reiterate Buy -> Buy
2025-08-19 HC Wainwright & Co. Reiterate Buy -> Buy
2025-08-15 HC Wainwright & Co. Maintains Buy -> Buy
2025-07-15 LUCID CAPITAL MARKETS Reiterate Buy -> Buy
2025-06-23 HC Wainwright & Co. Maintains Buy -> Buy
2025-03-19 Rodman & Renshaw Initiate Buy
2025-01-30 HC Wainwright & Co. Maintains Buy -> Buy
2025-01-07 B of A Securities Downgrade Buy -> Underperform
2025-01-06 Canaccord Genuity Maintains Buy -> Buy
2024-10-21 HC Wainwright & Co. Maintains Buy -> Buy
2024-09-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-30 Canaccord Genuity Maintains Buy -> Buy
2024-08-09 UBS Maintains Neutral -> Neutral
2024-08-08 HC Wainwright & Co. Maintains Buy -> Buy
2024-06-27 Canaccord Genuity Maintains Buy -> Buy
2024-05-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-23 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-14 Canaccord Genuity Maintains Buy -> Buy
2024-03-13 B of A Securities Maintains Buy -> Buy
2024-02-21 UBS Downgrade Buy -> Neutral
2023-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-31 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-26 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-05 Truist Securities Downgrade Buy -> Hold
2023-09-13 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-08 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-28 HC Wainwright & Co. Reiterate Buy -> Buy

BIOXCEL THERAPEUTICS INC / BTAI FAQ

How do analysts rate BIOXCEL THERAPEUTICS INC (BTAI)?

The consensus rating for BIOXCEL THERAPEUTICS INC (BTAI) is 78.1818 / 100 . This indicates that analysts generally have a positive outlook on the stock.